|
MCID: HYP315
|
Hyperparathyroidism, Neonatal malady |
|
Sources: 33OMIM, 22MalaCards See all sources Export this MalaCard |
MalaCards: Hyperparathyroidism, Neonatal, also known as hyperparathyroidism, is related to familial isolated hyperparathyroidism and multiple endocrine neoplasia. An important gene associated with Hyperparathyroidism, Neonatal is CASR (calcium-sensing receptor). The drugs calcitriol and dihydrotachysterol have been mentioned in the context of this disorder.
OMIM: 239200 |
|
Sources: 43UMLS, 33OMIM See all sources |
|
Sources: 33OMIM See all sources |
Clinical features from OMIM: 239200
|
|
Sources: 4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 43UMLS, 28NDF-RT See all sources |
Approved drugs:Search CenterWatch for hyperparathyroidism, neonatal Drug clinical trials:Search ClinicalTrials for hyperparathyroidism, neonatal Search NIH Clinical Center for hyperparathyroidism, neonatal Search CenterWatch for hyperparathyroidism, neonatal Inferred drug relations via UMLS/NDF-RT:43 28 calcitriol, cod liver oil [va product], dihydrotachysterol, doxercalciferol, paricalcitol |
|
|
|
|
|
|
|
|
|
Sources: 1BioGPS See all sources |
![]() |
|
|
|
|
|
|
